About: A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) клінічне випробування (uk)
rdfs:label	A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise (en)
skos:prefLabel	A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise (en)
name	A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise (en)
title	wds:Q65381401-4E13145B-742D-498F-A1ED-4BE057BBF8CD
title	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise (en)
end time	wds:Q65381401-82E78AAE-B395-4255-9C79-8E58CFFDF0F9
end time	2009-02-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65381401-8E0FD797-E789-4AD6-99C3-744F7A3BCCC6
instance of	clinical trial
start time	wds:Q65381401-12893495-38B9-4D42-BE1C-FFA6A54CF415
start time	2007-09-01 00:00:00Z (xsd:dateTime)
country	wds:Q65381401-5CE0F24E-ED1D-46CD-8D05-EB2F946E809B wds:Q65381401-6688BA75-92AC-4CC9-9A1D-058778242383 wds:Q65381401-FFE8F44A-A315-43DF-8086-430EB4A178F5
country	Mexico Malawi United States of America
research site	wds:Q65381401-112C6350-AA27-4043-9B99-294913234349
research site	Westside Center for Clinical Research
minimum age	wds:Q65381401-6D78919C-FDCA-43F1-8416-7AFE233B539F
minimum age	18 (xsd:decimal)
medical condition	wds:Q65381401-6067BE0C-5C23-4074-BE52-6A738D513E11
medical condition	diabetes
number of participants	wds:Q65381401-A603337C-EED6-45FF-84DA-E142D2526E37
number of participants	1067 (xsd:decimal)
contributor to the...e work or subject	wds:Q65381401-D72B9671-CF59-4484-A3C5-B3C38AF6147A
contributor to the...e work or subject	Bristol-Myers Squibb
maximum age	wds:Q65381401-B137D26A-A38C-4F76-B2AC-A62CC5A42183
maximum age	77 (xsd:decimal)
study type	wds:Q65381401-815B572D-9B7A-45F1-8E38-0C8D559F19B3
study type	interventional study
ClinicalTrials.gov ID	wds:Q65381401-45AE3A04-7A14-4D55-8C76-02FA565AAC9D
ClinicalTrials.gov ID	NCT00528372
clinical trial phase	wds:Q65381401-165E175C-CC1A-4DE0-9857-87143F12DCE6
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65381401

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software